Chemical Component Summary

Name2,6-BIS(1-METHYLETHYL)PHENOL
Identifiers2,6-di(propan-2-yl)phenol
FormulaC12 H18 O
Molecular Weight178.27
TypeNON-POLYMER
Isomeric SMILESCC(C)c1cccc(C(C)C)c1O
InChIInChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3
InChIKeyOLBCVFGFOZPWHH-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count31
Chiral Atom Count0
Chiral Atomsn/a
Bond Count31
Aromatic Bond Count6
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00818 Different stereochemistry
NamePropofol
Groups
  • approved
  • investigational
  • vet_approved
DescriptionPropofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Synonyms
  • 2,6-Bis(1-methylethyl)phenol
  • 2,6-Diisopropylphenol
  • Diprivan
  • Disoprivan
  • Disoprofol
Brand Names
  • Act Propofol
  • Diprivan
  • Diprivan Eml IV 1%
  • PMS-propofol
  • Propofol
Affected OrganismHumans and other mammals
IndicationUsed for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
PharmacologyPropofol is a sedative-hypnotic agent for use in the induction and maintenance of anesthesia or sedation. Intravenous injection of a therapeutic dose of propofol produces hypnosis rapidly with minimal excitation, usually within 40 seconds from the start of an injection (the time for one arm-brain circulation).
Mechanism of actionThe action of propofol involves a positive modulation of the inhibitory function of the neurotransmitter gama-aminobutyric acid (GABA) through GABA-A receptors.
Route of administrationIntravenous
Categories
  • Anesthetics
  • Anesthetics, General
  • Anesthetics, Intravenous
  • Benzene Derivatives
  • Central Nervous System Agents
ATC-CodeN01AX10
AHFS-Code28:04.92
CAS number2078-54-8
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682